YU45295A - Supstituisani benzamidini, njihovo pripremanje i primena kao lekova - Google Patents

Supstituisani benzamidini, njihovo pripremanje i primena kao lekova

Info

Publication number
YU45295A
YU45295A YU45295A YU45295A YU45295A YU 45295 A YU45295 A YU 45295A YU 45295 A YU45295 A YU 45295A YU 45295 A YU45295 A YU 45295A YU 45295 A YU45295 A YU 45295A
Authority
YU
Yugoslavia
Prior art keywords
benzamidines
medicines
substituted
preparation
achtagorists
Prior art date
Application number
YU45295A
Other languages
English (en)
Other versions
YU48934B (sh
Inventor
R. Anderskewitz
K. Schromm
E-O. Renth
F. Birke
A. Fugner
H. Hener
C. Meade
Original Assignee
Boehringer Ingelheim Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg. filed Critical Boehringer Ingelheim Kg.
Publication of YU45295A publication Critical patent/YU45295A/sh
Publication of YU48934B publication Critical patent/YU48934B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
    • C07C271/64—Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/18—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Nova jedinjenja (značenje za A i Rj do R4 objašnjeno je u opisu) i mogu se pripremiti prema konvencionalnim metodama, a imogu između ostalog, da se terapeutski upotrebe kao LTB4 ahtagoristi.
YU45295A 1994-07-13 1995-07-06 Supstituisani benzamidini, njihovo pripremanje i primena kao lekova YU48934B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4424713A DE4424713A1 (de) 1994-07-13 1994-07-13 Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe

Publications (2)

Publication Number Publication Date
YU45295A true YU45295A (sh) 1997-12-05
YU48934B YU48934B (sh) 2002-12-10

Family

ID=6523047

Family Applications (1)

Application Number Title Priority Date Filing Date
YU45295A YU48934B (sh) 1994-07-13 1995-07-06 Supstituisani benzamidini, njihovo pripremanje i primena kao lekova

Country Status (36)

Country Link
US (1) US5731332A (sh)
EP (1) EP0770059B1 (sh)
JP (1) JP2931410B2 (sh)
KR (1) KR100421580B1 (sh)
CN (1) CN1083830C (sh)
AT (1) ATE178590T1 (sh)
AU (1) AU700585B2 (sh)
BG (1) BG62090B1 (sh)
BR (1) BR9508374A (sh)
CA (1) CA2194885C (sh)
CO (1) CO4410184A1 (sh)
CZ (1) CZ289376B6 (sh)
DE (2) DE4424713A1 (sh)
DK (1) DK0770059T3 (sh)
EE (1) EE03311B1 (sh)
ES (1) ES2131830T3 (sh)
FI (1) FI970094L (sh)
GR (1) GR3030043T3 (sh)
HR (1) HRP950365B1 (sh)
HU (1) HU224823B1 (sh)
IL (1) IL114571A (sh)
MX (1) MX9700273A (sh)
MY (1) MY117090A (sh)
NO (1) NO307373B1 (sh)
NZ (1) NZ287883A (sh)
PE (1) PE32496A1 (sh)
PL (1) PL179595B1 (sh)
RO (1) RO118653B1 (sh)
RU (1) RU2159228C2 (sh)
SA (1) SA95160355B1 (sh)
SK (1) SK281744B6 (sh)
TW (1) TW555738B (sh)
UA (1) UA45351C2 (sh)
WO (1) WO1996002497A1 (sh)
YU (1) YU48934B (sh)
ZA (1) ZA955780B (sh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486181B1 (en) 1992-08-28 2002-11-26 City Of Hope Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states
US6191169B1 (en) 1992-08-28 2001-02-20 City Of Hope Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
ATE251141T1 (de) * 1995-03-10 2003-10-15 Berlex Lab Benzamidin-derivate, deren herstellung und deren verwendung als anti-koagulantien
EP0743064A1 (en) * 1995-05-17 1996-11-20 Eli Lilly And Company Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
DE19718334A1 (de) * 1997-04-30 1998-11-05 Boehringer Ingelheim Pharma Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
TW513402B (en) * 1997-05-30 2002-12-11 Daiichi Seiyaku Co Process for preparing 3-(7-amidino-2-naphthyl)-2-phenylpropionic acid derivatives
AU1081399A (en) * 1997-10-15 1999-05-03 City Of Hope 12(s)-hete receptor blockers
ID24720A (id) 1997-12-12 2000-08-03 Novartis Ag Senyawa amidino tersubstitusi dalam perawatan penyakit gangguan paru-paru kronis
DE19834713A1 (de) * 1998-07-31 2000-02-03 Boehringer Ingelheim Pharma Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6291531B1 (en) * 1999-10-07 2001-09-18 Boehringer Ingelheim Pharma Kg LTB4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition
DE10000907A1 (de) * 2000-01-12 2001-07-19 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Aryl-iminomethyl-carbaminsäureestern
US6417382B2 (en) 2000-01-12 2002-07-09 Boehringer Ingelheim Pharma Kg Process for preparing aryl-iminomethyl-carbamino acid esters
US6528491B2 (en) * 2000-10-24 2003-03-04 Boehringer Ingelheim Pharma Kg Pyranoside derivatives
JP2004523512A (ja) 2001-01-16 2004-08-05 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト ムチン遺伝子の増大された発現により生じる疾患の治療及び／又は予防のためのｌｔｂ４アンタゴニストの使用
US20030119901A1 (en) * 2001-07-14 2003-06-26 Boehringer Ingelheim Pharma Kg Pharmaceutical formulation containing an LTB4 antagonist
MXPA04000384A (es) * 2001-07-14 2004-05-04 Boehringer Ingelheim Pharma Formulacion de medicamento que contiene antagonista de ltb4.
IL160208A0 (en) * 2001-08-31 2004-07-25 Neurochem Int Ltd Amidine derivatives for treating amyloidosis
RS20050390A (sr) * 2002-11-26 2008-04-04 Boehringer Ingelheim Pharma Gmbh. & Co.Kg., Farmaceutska kompozicija koja obuhvata ltb4 antagonist i koks-2 inhibitor ili kombinovani koks1/2 inhibitor
DE10350528A1 (de) * 2003-10-29 2005-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Arzneimittelformulierung, enthaltend einen LTB4-Antagonisten, sowie Verfahren zu deren Herstellung und deren Verwendung
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
ES2333739T3 (es) * 2004-11-23 2010-02-26 Dong Wha Pharmaceutical Co., Ltd. Sal de n-hidroxi-4-(5-(4-(5-isopropil-2-metil-1,3-tiazol-4-il)fenoxi) pentoxi)benzamidina con acido 2-metanosulfonico.
CN103012200B (zh) * 2011-09-20 2014-12-17 北京大学 具有β-分泌酶抑制功能的化合物及其制备方法与应用
US12275687B2 (en) 2017-05-12 2025-04-15 Riken Class A GPCR-binding compound modifier

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550192B1 (fr) * 1983-08-03 1986-04-04 Sanofi Sa Nouveaux derives de la benzamidine a activite antimicrobienne, leur procede de preparation, leur utilisation en tant que medicaments desinfectants ou conservateurs
DK0518819T3 (da) * 1991-06-11 1995-09-25 Ciba Geigy Ag Amidino-forbindelser, deres fremstilling og anvendelse som lægemiddel
EP0518818A3 (en) * 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
US5451700A (en) * 1991-06-11 1995-09-19 Ciba-Geigy Corporation Amidino compounds, their manufacture and methods of treatment
DE59310252D1 (de) * 1992-02-05 2002-01-24 Boehringer Ingelheim Pharma Neue Amiderivate, ihre Herstellung und Verwendung als Arzneimittel mit LTB4-antagonistischer Wirkung
US5455274A (en) * 1992-12-09 1995-10-03 Ciba-Geigy Corporation Hydroxyamidine derivatives

Also Published As

Publication number Publication date
TW555738B (en) 2003-10-01
CZ289376B6 (cs) 2002-01-16
CA2194885A1 (en) 1996-02-01
HRP950365A2 (en) 1997-08-31
ES2131830T3 (es) 1999-08-01
FI970094A7 (fi) 1997-01-10
RO118653B1 (ro) 2003-08-29
CA2194885C (en) 2006-04-25
NO970122L (no) 1997-01-10
EP0770059B1 (de) 1999-04-07
HU9700059D0 (en) 1997-02-28
KR100421580B1 (ko) 2004-07-31
UA45351C2 (uk) 2002-04-15
PL179595B1 (pl) 2000-09-29
YU48934B (sh) 2002-12-10
CN1152304A (zh) 1997-06-18
HK1011966A1 (en) 1999-07-23
DE59505600D1 (de) 1999-05-12
JP2931410B2 (ja) 1999-08-09
CN1083830C (zh) 2002-05-01
AU2674295A (en) 1996-02-16
IL114571A (en) 2003-09-17
NO970122D0 (no) 1997-01-10
MX9700273A (es) 1997-05-31
DK0770059T3 (da) 1999-10-18
HUT77220A (hu) 1998-03-02
SK281744B6 (sk) 2001-07-10
HRP950365B1 (en) 2000-04-30
IL114571A0 (en) 1995-11-27
US5731332A (en) 1998-03-24
BR9508374A (pt) 1998-05-26
EE03311B1 (et) 2000-12-15
NZ287883A (en) 1999-02-25
CZ6697A3 (cs) 1998-02-18
EP0770059A1 (de) 1997-05-02
BG101105A (bg) 1998-04-30
WO1996002497A1 (de) 1996-02-01
FI970094A0 (fi) 1997-01-10
BG62090B1 (bg) 1999-02-26
SK1997A3 (en) 1997-08-06
FI970094L (fi) 1997-01-10
GR3030043T3 (en) 1999-07-30
RU2159228C2 (ru) 2000-11-20
PE32496A1 (es) 1996-08-12
HU224823B1 (en) 2006-02-28
MY117090A (en) 2004-05-31
JPH10502645A (ja) 1998-03-10
DE4424713A1 (de) 1996-01-18
ATE178590T1 (de) 1999-04-15
AU700585B2 (en) 1999-01-07
CO4410184A1 (es) 1997-01-09
KR970704675A (ko) 1997-09-06
ZA955780B (en) 1996-01-15
NO307373B1 (no) 2000-03-27
PL318115A1 (en) 1997-05-12
SA95160355B1 (ar) 2005-06-13

Similar Documents

Publication Publication Date Title
YU45295A (sh) Supstituisani benzamidini, njihovo pripremanje i primena kao lekova
YU133090A (sh) Novi heteroazepini s paf-antaganostičnim učinkom in postopek za njihovo pripravo
DE69012008D1 (de) Vorbereitung eines Zellklumpens.
HUT37418A (en) Process for producing new 2,2'-imino-bis/ethanol/ derivatives and pharmaceutical compositions sontaining them as active agents
YU55683A (en) Process for expressiation, altering and excreting heterologic proteine by using yeast
AU5058585A (en) Analgesic compositions
EP0272534A3 (de) 8-Substituierte 2-Aminotetraline
JPS57116030A (en) 2-phenylethanol amine derivative, manufacture and medicinal composition
DK0712426T3 (da) Fluorescerende latex, som omfatter i det mindste to fluorokromer, fremgangsmåde til fremstilling deraf samt anvendelse deraf
IT8548344A0 (it) Composti monoazoici,anionici,loro preparazione e loro impiego come coloranti
DE68913050D1 (de) Antithrombotische zusammensetzung.
AU8973482A (en) 1,8,9 trihydroxyanthracene in form of shampoo
IL72368A0 (en) New benzothiazepines with cardiovascular utility,methods for their preparations and pharmaceutical compositions
DE3475164D1 (en) Synergistic pharmaceutical compositions, their production and use
AU8111282A (en) 1,2,3,6 tetrahydropyridines as anorectic agents
AU565273B2 (en) Polymer cross linking composition
AU6285390A (en) Improvements in or relating to i.c. engines
FI854171A7 (fi) 1,4-dihydropyridiini-hydroksiamiineja, menetelmä niiden valmistamiseksi samoin kuin niiden käyttö lääkeaineina.
AU561025B2 (en) 2,2-dimethyl-5-phenoxypentanoic acid benzamides
AU578633B2 (en) 3-5-diacyl-4-aryl-1,4-dihydropyridines,their manufacture and use and pharmaceutical compositions
EP0493601A4 (en) Liquid-crystal copolymer, production thereof, diene compound used in said production, and production of said compound
AU2602284A (en) Benzimidzole derivative, polymer, and ion-exchanger
AU572969B2 (en) Photopolymerizable block copolymer composition
AU2192783A (en) 3:,5:-diarabinosides preparation and application in therapy
IT8424266A0 (it) Composizioni farmaceutiche e loro uso come midriatici.